Naloxegol Oxalate
Brand name: Movantik
Rank #311 of 500 drugs by total cost
$36.1M
Total Cost
85,094
Total Claims
$36.1M
Total Cost
3,549
Prescribers
$424
Cost per Claim
7,823
Beneficiaries
94,750
30-Day Fills
$10K
Avg Cost/Provider
24
Avg Claims/Provider
About Naloxegol Oxalate
Naloxegol Oxalate (sold as Movantik) was prescribed 85,094 times by 3,549 Medicare Part D providers in 2023, costing the program $36.1M. At $424 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 308 | Tizanidine Hcl (Tizanidine Hcl) | $36.5M | 2,602,362 |
| 309 | Fentanyl (Fentanyl) | $36.2M | 324,419 |
| 310 | Alprazolam (Alprazolam) | $36.1M | 4,899,372 |
| 311 | Naloxegol Oxalate (Movantik) | $36.1M | 85,094 |
| 312 | Valacyclovir Hcl (Valacyclovir) | $35.9M | 827,731 |
| 313 | Sodium Oxybate (Xyrem) | $35.8M | 2,160 |
| 314 | Lisdexamfetamine Dimesylate (Lisdexamfetamine Dimesylate) | $35.7M | 88,692 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology